Infographic | September 13, 2022

Top Therapeutic Areas for Highly Potent API

Source: ISR Reports

In Q1 of 2022, ISR asked 100 people who outsource highly potent drug substance what therapeutic areas their medications are designed to target. The most common response is Oncology with roughly three-quarters of respondents confirming the indication (73 percent). Immunology (36 percent) follows with one-third of respondents targeting the therapeutic area. Hematology (23 percent) and Neurology (22 percent) nearly tie for third position, each with roughly one-quarter of respondents confirming the targeted area. To learn more, follow the link to the Highly Potent API Market Outlook report preview.

VIEW THE INFOGRAPHIC!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online